iURO Pelvic Floor is the must-have app for all pelvic floor healthcare professionals and students. The narrated simulation videos make it easy to understand and explain the different pathologies and therapies. It can be used by doctors, nurses and pelvic floor physical therapists to enhance communication with their patients. Medical students can use iURO apps to increase their knowledge and understanding of various urological topics.
iURO Pelvic Floor can also be used by patients directly, to familiarize themselves with the different aspects of their pelvic floor condition and the treatment options available.
Features include:
Narrated simulation videos to explain the pelvic floor area
Narrated simulation videos to explain conditions related to the pelvic floor
Narrated simulation videos to explain different treatment options
Draw on picture, offering the opportunity to draw on and make personalized notes on a 3D image
Send this customized 3D image directly to patients or colleagues by email
360 image of the kidney, offering the opportunity to zoom on the 3D image from every angle
iURO apps are created in consultation with urologists in order to provide a realistic representation of pathologies and therapies. iURO apps are prepared with the aim of enhancing communication and education options. If you are not a healthcare professional, please note that iURO apps support but never substitute the relation with your healthcare professional.
App Management:
Scientific Director: Carlos Rioja, Hospital Royo Villanova, Zaragoza, Spain
Scientific Director: Jorge Rioja, Hospital Miguel Servet, Zaragoza, Spain
Scientific Director: Sanjeev Bandi, Mackay Urology, Mackay Australia
iURO Scientific Advisory Board:
Lithiasis
Olivier Traxer, University Pierre et Marie Curie Paris, France
Adrian Joyce, Spire Leeds Hospital in Roundhay, Leeds, Yorkshire, United Kingdom
Benign Prostatic Hyperplasia
Jean de la Rosette, AMC University Hospital, Amsterdam, The Netherlands
Matthias Oelke, Hanover Medical School, Hanover, Germany
Pelvic Floor Disorder, Functional and Female Urology
David Castro, University of La Laguna, Tenerife, Spain
Dirk De Ridder, Kliniekhoofd Urologie UZ, Leuven, Belgium
Oncology
Karim Touijer, Memorial Sloan Kettering Cancer Center, New York, USA
Raul Parra, Memorial Sloan Kettering Cancer Center, New York, USA
Peter Scardino, Memorial Sloan Kettering Cancer Center, New York, USA
Pilar Laguna, AMC University Hospital, Amsterdam
Sharokh Shariat, Weill Medical College of Cornell University, New York, USA
Theo de Reijke, AMC University Hospital Amsterdam, The Netherlands
Octavio Castillo Cadiz, Clnica Indisa, Santiago, Chile
Jaime Landman, University of California Irvine, Los Angeles, USA
Andrology
Eduard Garcia, University Hospital Clcic de Barcelona, Barcelona, Spain
Juan Ignacio Martinez Salamanca, University Hospital Puerta de Hierro Majadahonda, Autonomous University of Madrid, Madrid, Spain
Ignacio Moncada, Hospital La Zarzuela, Madrid, Spain
David J Ralph, St Peters Andrology Centre, London, United Kingdom
Nelson Bennett, Lahey Hospital and Medical Center, Burlington, USA
Rados Djinovic, Sava Perovic Foundation, Belgrade, Serbia